Zhang Bo, Pang Qing-Jiang, Zhang Hai-Jun, Yuan Yi
Department of Orthopaedics ,the 2nd Hospital of Ningbo, Ningbo 315010, Zhejiang, China.
Zhongguo Gu Shang. 2011 Dec;24(12):982-6.
To determin the prognostic factors that influence survival in patients with osteosarcma.
The clinical data of 43 patients with osteosarcoma between March 2005 and March 2007 were retrospectively reviewed. Patient's sex, age, tumor site, course of disease, serum alkaline phosphatase (AKP) level, preoperative chemotherapy, Enneking surgical stage, surgical method, distant metastasis were analyzed by Kaplan-Meier method, Log-rank test and COX regression model. Kaplan-Meier method was used to calculate the 3-years survival rate, and Log-rank test was used to determin prognostic factors related with survival rate, and COX regression model was used to find the independent prognostic factors. The effect of neoadjuvant chemotherapy on the prognosis of osteosarcoma was analyzed by Fisher exact test.
All the patients were followed up. Twenty-eight patients were alive, while 15 patients were dead. The survival time ranged from 6 to 65 months with a median survival of 42 months. Overall 3-year survival rate was 65.1%. Univariate analysis revealed that the prognosis of osteosarcoma was significantly related to tumor site (P = 0.010), Enneking surgical stage (P = 0.002), surgical method (P = 0.000) and distant metastasis (P = 0.002). Multivariate analysis by COX regression model suggested Enneking surgical stage (P = 0.028),surgical method (P = 0.001) and distant metastasis (P = 0.007) were the independent prognostic factors. Though the preoperative chemotherapy was unrelated to the survival of osteosarcoma, the sensitivity to preoperative chemotherapy was an important factor that affected the prognosis of osteosarcoma (P = 0.007).
The prognosis of osteosarcoma was significantly correlated with Enneking surgical stage, surgical method and distant metastasis, early detection and wide excision were interventional methods to improve the survival of osteosarcoma.
确定影响骨肉瘤患者生存的预后因素。
回顾性分析2005年3月至2007年3月期间43例骨肉瘤患者的临床资料。采用Kaplan-Meier法、Log-rank检验和COX回归模型分析患者的性别、年龄、肿瘤部位、病程、血清碱性磷酸酶(AKP)水平、术前化疗、Enneking手术分期、手术方法、远处转移情况。用Kaplan-Meier法计算3年生存率,用Log-rank检验确定与生存率相关的预后因素,用COX回归模型找出独立预后因素。采用Fisher确切概率法分析新辅助化疗对骨肉瘤预后的影响。
所有患者均获随访。28例患者存活,15例患者死亡。生存时间为6至65个月,中位生存时间为42个月。总体3年生存率为65.1%。单因素分析显示,骨肉瘤的预后与肿瘤部位(P = 0.010)、Enneking手术分期(P = 0.002)、手术方法(P = 0.000)和远处转移(P = 0.002)显著相关。COX回归模型多因素分析提示,Enneking手术分期(P = 0.028)、手术方法(P = 0.001)和远处转移(P = 0.007)是独立预后因素。虽然术前化疗与骨肉瘤的生存无关,但对术前化疗的敏感性是影响骨肉瘤预后的重要因素(P = 0.007)。
骨肉瘤的预后与Enneking手术分期、手术方法和远处转移显著相关,早期发现和广泛切除是提高骨肉瘤患者生存率的干预措施。